fb-pixel Skip to main content

Latest Headlines in Biotech

The Moderna COVID-19 vaccine.

Moderna seeks full FDA approval for its COVID-19 vaccine

If regulators grant the approval, it would follow the full clearance earlier this week of the vaccine made by Pfizer and BioNTech.

Boston has received three bids for its nondescript office building at 22 Drydock Ave. in the city's marine industrial park.

Another piece of Boston’s old industrial waterfront is poised to become . . . lab space

Here's a look at the proposals, which all involve putting up lab buildings that are seven or eight stories high.

The Pfizer building in Cambridge.

Pfizer to acquire cancer drugmaker Trillium for $2.3 billion

Trillium’s two lead molecules block signaling proteins involved in blood cancers and are both in human trials across several types of disease.

RNA for GreenLight Biosciences' agriculture products at its facility in Rochester, New York.

Medford RNA firm GreenLight Biosciences to go public in $1.2b deal

The company’s research includes pesticide alternatives and a COVID-19 vaccine candidate.

In all, Moderna expects to send 25 million doses of its COVID-19 vaccine to Australia.

Moderna’s vaccine gets provisional OK in Australia

The Cambridge company says the first 10 million doses will start shipping next month.

Tillman Gerngross, Co-Founder and CEO, Adagio Therapeutics.

Adagio raises $300 million in IPO, looks to advance COVID-19 antibody therapy

The company said it could seek emergency use approval from the FDA for its treatment in early 2022.

EQRx’s Alexis Borisy and Melanie Nallicheri.

EQRx to go public in $1.8 billion SPAC deal, with plan to make drugs cost less

The Cambridge startup says some of its late-stage programs would address cancer and inflammatory conditions.

Moderna says its COVID vaccine remains effective after six months, but booster needed before winter

The Cambridge company’s vaccine remained 93 percent effective six months after people received the second shot, Moderna said Thursday, although the data was totaled before the emergence of the highly contagious Delta variant.